For several quarters, the knock on Addus HomeCare was that its personal care business grew revenue mostly through rate increases while the number of people it actually served drifted sideways or lower. Last quarter that changed. Same-store census rose 1.2% sequentially, and Illinois, the company's largest market, returned to year-over-year growth. When Addus reports third-quarter results after the close on November 3, the core question is whether that inflection was the start of a trend or a single good quarter. The stock has already moved on the first answer.

Wall Street expects adjusted earnings of $1.78 a share on revenue of $388.4 million. That revenue figure implies growth of about 7.2% from the $362.3 million posted a year ago and a modest step up from last quarter's $377.4 million. That is solid but unspectacular expansion for a company that has leaned on acquisitions and state rate increases. On earnings, the consensus sits only slightly above the $1.73 in adjusted EPS that Addus delivered last quarter. The Earnings Whisper of $1.82 is a few cents above the published estimate. That points to a bar that is a bit higher than the official numbers suggest, though not dramatically so.

The rate backdrop explains why census matters so much now. Illinois will not grant a rate increase this budget cycle after a 3.9% bump in January, so growth there has to come from serving more clients and filling more authorized hours. Management credited its caregiver app, which is ramping faster than planned in Texas, for lifting the share of authorized hours served into the mid-80s from the low 80s. Another sequential census gain and a fill rate that holds or improves would validate that story. Census slipping back toward flat, or Texas remaining stuck while hiring cools, would challenge it. Daily hires already eased to 104 from 108 last quarter. New Mexico offers a potential offset, since a roughly 4% rate pass-through under negotiation with managed care plans was expected to help the second half.

Margins are the second test. Adjusted EBITDA margin hit 13.0% last quarter, and management steered toward the high end of its 12% to 13% full-year range. Holding near that level would show the improvement reflects operating leverage rather than a favorable mix in one quarter. Two drags complicate the earnings math, however. The expiration of the work opportunity tax credit has pushed the tax rate into the upper 20s, which trims EPS even if operations perform. In hospice, a roughly $3 million Medicare cap accrual in Ohio surprised investors after management had flagged no cap concerns a quarter earlier. Any further accruals would raise questions about whether the problem is spreading. Home health, where same-store revenue declines narrowed to 2.8% from 6.6% under new leadership, needs to keep closing that gap.

Capital deployment adds upside optionality. Bank debt fell to $64.3 million from $124.3 million two quarters earlier, and management sounded more willing to pursue larger deals, including home health assets after a friendlier 2027 proposed payment rule. The Indiana Home Court deal now contributes a full quarter, and an update on the pending second Indianapolis acquisition would help confirm the pipeline is real.

Sentiment remains net bearish but has improved meaningfully, to 28.2% bearish from 40.4% before the last report. The stock has risen 11% since then while the S&P 500 was flat. At $121.81, shares sit well above the 200-day moving average and within about 1% of their post-earnings high of $123.19, testing a breakout above levels last quarter never reached. That leaves less room for a merely adequate print. The narrative stays intact if census grows again and margins hold near 13% despite the tax headwind. A stall in census would suggest the market got ahead of the turnaround.